ArticleScientific reports2025
Optimizing the compliance third-party supervision workflow of involved enterprises using artificial intelligence ant colony algorithm.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This article optimized the compliance third-party supervision workflow of the involved enterprises based on the artificial intelligence ant colony optimization (ACO) algorithm. The basic principles and application advantages of ACO were introduced, and a heuristic information matrix was defined using ACO to optimize the data collection and analysis stage of the compliance third-party supervision workflow. During the experimental phase, a feasibility analysis was conducted on the optimization of third-party supervision workflows for compliance by ACO involved enterprises through simulation experiments. The experiments were evaluated from four aspects: data quality, model performance, scheme effectiveness, and supervision effectiveness. Among the metrics data for the ACO-optimized test set were 0.03 and 0.025 for MSE (Mean Square Error) and Γ, 0.8, 0.78, 0.79, and 0.88 for Accuracy, Recall, F1 Score, and AUC-ROC (Area Under the Curve-Receiver Operating Characteristic), and 0.28, 0.4, 0.88, and 0.12 for CER (Cost-Effectiveness Ratio), NPV (Net Present Value), SCR (Supervision Coverage Rate), and CRC (Compliance Rate Change), respectively. The experimental results showed that, in terms of data quality, model performance, scheme effectiveness, and supervision effectiveness, the evaluation indicators of the compliance third-party supervision workflow of the involved enterprises optimized using ACO were superior to those without ACO optimization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.